{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:16:27Z","timestamp":1792588587636,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,8]]},"DOI":"10.1093\/infdis\/jiy739","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T15:21:22Z","timestamp":1545405682000},"page":"1545-1546","source":"Crossref","is-referenced-by-count":34,"title":["Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel?"],"prefix":"10.1093","volume":"220","author":[{"given":"Roland W","family":"Sutter","sequence":"first","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L","family":"Cochi","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2019100813084126500_CIT0001","volume-title":"Polio eradication & endgame strategic plan 2013\u20132018","author":"Global Polio Eradication Initiative","year":"2013"},{"key":"2019100813084126500_CIT0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jix117","article-title":"Polio endgame & legacy: implementation, best practices, and lessons learned","volume":"216","author":"Patel","year":"2017","journal-title":"J Infect Dis"},{"key":"2019100813084126500_CIT0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jiw626","article-title":"Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines-lessons learned from the global perspective","volume":"216","author":"Ramirez Gonzalez","year":"2017","journal-title":"J Infect Dis"},{"key":"2019100813084126500_CIT0004","doi-asserted-by":"crossref","first-page":"538","DOI":"10.15585\/mmwr.mm6620a4","article-title":"Virologic monitoring of poliovirus type 2 after oral poliovirus vaccine type 2 withdrawal in April 2016 - worldwide, 2016-2017","volume":"66","author":"Diop","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019100813084126500_CIT0005","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6742a5","article-title":"Update on vaccine-derived polioviruses - worldwide, January 2017-June 2018","volume":"67","author":"Jorba","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019100813084126500_CIT0006","volume-title":"IPV introduction status"},{"key":"2019100813084126500_CIT0007","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule","volume":"35","author":"Anand","year":"2017","journal-title":"Vaccine"},{"key":"2019100813084126500_CIT0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose-sparing option for polio immunization","volume":"216","author":"Okayasu","year":"2017","journal-title":"J Infect Dis"},{"key":"2019100813084126500_CIT0009","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/434699a","article-title":"A global call for new polio vaccines","volume":"434","author":"Heymann","year":"2005","journal-title":"Nature"},{"key":"2019100813084126500_CIT0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development","volume":"44","author":"Okayasu","year":"2016","journal-title":"Biologicals"},{"key":"2019100813084126500_CIT0011","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy736","article-title":"Immunogenicity and safety of a Sabin strain\u2013based inactivated poliovirus vaccine: a phase 3 clinical trial","author":"Hu","year":"2019","journal-title":"J Infect Dis"},{"key":"2019100813084126500_CIT0012","volume-title":"Prequalification of vaccines for procurement of UN agencies"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/10\/1545\/30120805\/jiy739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/10\/1545\/30120805\/jiy739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T13:08:53Z","timestamp":1570540133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/10\/1545\/5432103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":12,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2019,10,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy739","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,15]]},"published":{"date-parts":[[2019,4,8]]}}}